UA108546U - METHOD OF TREATMENT OF PATIENTS WITH HODZHKIN II STAGE LYMPHOMA - Google Patents

METHOD OF TREATMENT OF PATIENTS WITH HODZHKIN II STAGE LYMPHOMA

Info

Publication number
UA108546U
UA108546U UAU201512832U UAU201512832U UA108546U UA 108546 U UA108546 U UA 108546U UA U201512832 U UAU201512832 U UA U201512832U UA U201512832 U UAU201512832 U UA U201512832U UA 108546 U UA108546 U UA 108546U
Authority
UA
Ukraine
Prior art keywords
patients
treatment
hodzhkin
lymphoma
stage
Prior art date
Application number
UAU201512832U
Other languages
Ukrainian (uk)
Inventor
Ірина Анатоліївна Крячок
Олена Михайлівна Алексик
Ірина Борисівна Титоренко
Алім Анварович Амдієв
Ольга Ігоревна Новосад
Original Assignee
Національний Інститут Раку
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Інститут Раку filed Critical Національний Інститут Раку
Priority to UAU201512832U priority Critical patent/UA108546U/en
Publication of UA108546U publication Critical patent/UA108546U/en

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

Спосіб лікування хворих на лімфому Ходжкіна IIВ стадії, що включає хіміотерапевтичне лікування. Після 2-го курсу за схемою BEACOPP-esc, у разі досягнення часткової або повної відповіді на терапію, хворому призначають курси ПХТ за схемою ABVD з подальшою променевою терапією на початкову пухлинну масу.A method of treating patients with stage Hodgkin's lymphoma, including chemotherapy treatment. After the 2nd course of the BEACOPP-esc scheme, in the event of partial or complete response to therapy, the patient is prescribed ABVD PCT courses with subsequent radiation therapy to the initial tumor mass.

UAU201512832U 2015-12-25 2015-12-25 METHOD OF TREATMENT OF PATIENTS WITH HODZHKIN II STAGE LYMPHOMA UA108546U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201512832U UA108546U (en) 2015-12-25 2015-12-25 METHOD OF TREATMENT OF PATIENTS WITH HODZHKIN II STAGE LYMPHOMA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201512832U UA108546U (en) 2015-12-25 2015-12-25 METHOD OF TREATMENT OF PATIENTS WITH HODZHKIN II STAGE LYMPHOMA

Publications (1)

Publication Number Publication Date
UA108546U true UA108546U (en) 2016-07-25

Family

ID=56562901

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201512832U UA108546U (en) 2015-12-25 2015-12-25 METHOD OF TREATMENT OF PATIENTS WITH HODZHKIN II STAGE LYMPHOMA

Country Status (1)

Country Link
UA (1) UA108546U (en)

Similar Documents

Publication Publication Date Title
MX2021004821A (en) Methods of cancer treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy.
MX2023001527A (en) Compounds with ferroptosis inducing activity and methods of their use.
WO2020121310A3 (en) Method of treating cancer with a cancer therapy in combination with another therapeutic agent
SG10201811841UA (en) Methods of treating cancer using tigit inhibitors and anti-cancer agents
MX2022008868A (en) Treatment of cancer with tg02.
NI201400095A (en) METHODS FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER USING COMBINED THERAPY OF INHIBITOR TOR KINASE.
EA201491221A1 (en) NEW MOLECULES INHIBITING JNK TO TREAT DIFFERENT DISEASES
MY194341A (en) Method of treating a brain tumor
MX2015014599A (en) Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer.
WO2015197193A3 (en) New use for jnk inhibitor molecules for treatment of various diseases
CY1123501T1 (en) USE OF RESLIZUMAB IN THE TREATMENT OF MODERATE TO SEVERE EOSINOPHILIC ASTHMA
MX2021010173A (en) Compounds with ferroptosis inducing activity and methods of their use.
PH12017500392A1 (en) Medical treatments based on anamorelin
MX2019013862A (en) Combination therapy.
MX2015012444A (en) Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens.
EA202193276A1 (en) METHODS FOR THE TREATMENT OF CHOLANGIOCARCINOMA
MX2017013666A (en) Anti-fugetactic agent and immunotherapy agent combination therapy and compositions for the treatment of cancer.
EA201891008A2 (en) TREATMENT OF SYMPTOMS ASSOCIATED WITH ANDROGEN-DEPRIVATION THERAPY
UA108546U (en) METHOD OF TREATMENT OF PATIENTS WITH HODZHKIN II STAGE LYMPHOMA
UA113183C2 (en) METHOD OF ADIATION TREATMENT
EA201990411A1 (en) METHODS OF TREATING PROSTATE CANCER
UA98863U (en) Method for treating endometrial hyperplasia of patients of reproductive age
UA112357C2 (en) METHOD OF INDIVIDUAL TARGET THERAPY OF VITAMIN D DEFICIENCY IN PATIENTS WITH BONE AND MUSCLE DISEASES
RU2014116784A (en) METHOD FOR TREATING PERIODONTAL DISEASES
UA108484U (en) METHOD OF TREATMENT OF PATIENTS WITH NON-HJK PRIMARY MEDIASTINAL B-BELL LYMPHOMA